Intralesional 5-Fluorouracil: A Therapy for Solitary Infantile Myofibromatosis
- PMID: 36943733
- DOI: 10.1097/DSS.0000000000003731
Intralesional 5-Fluorouracil: A Therapy for Solitary Infantile Myofibromatosis
References
-
- Larralde Margarita, Ferrari Bruno, Martinez JP, Barbieri MAF, et al. Infantile myofibromatosis. Bras Dermatol 2017;92:854–7.
-
- Rokos James, Carlos Roman, Romañach MarioJose. Clinical pathologic conference case 6: infantile myofibroma. Head Neck Pathol 2011;5:292–5.
-
- Hicks John, Mierau G. The spectrum of pediatric fibroblastic and myofibroblastic tumors. Ultrastructural Pathol 2004;28:265–81.
-
- Cheung Y, Gayden Tenzin, Campeau PhilippeM, LeDuc CharlesA, et al. A recurrent PDGFRB mutation causes familial infantile myofibromatosis. Am J Hum Genet 2013;92:996–1000.
-
- de Waard JW, de Man BM, Wobbes T, van der Linden CJ, et al. Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil. Eur J Cancer 1998;34:162–7.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
